Petra Rozsívalová

ORCID: 0000-0001-6114-3871
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pharmaceutical studies and practices
  • Chronic Lymphocytic Leukemia Research
  • Lymphoma Diagnosis and Treatment
  • COVID-19 Clinical Research Studies
  • Pharmaceutical Practices and Patient Outcomes
  • SARS-CoV-2 and COVID-19 Research
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Blood disorders and treatments
  • Immunodeficiency and Autoimmune Disorders
  • Medication Adherence and Compliance
  • Pneumonia and Respiratory Infections
  • Antibiotics Pharmacokinetics and Efficacy
  • Diabetes Management and Research
  • Actinomycetales infections and treatment
  • Biomedical and Engineering Education
  • Treatment of Major Depression
  • Drug-Induced Adverse Reactions
  • Pituitary Gland Disorders and Treatments
  • Surgical Sutures and Adhesives
  • Biomedical Ethics and Regulation
  • Medical Practices and Rehabilitation
  • Antibiotic Use and Resistance
  • COVID-19 Impact on Reproduction
  • Antibiotic Resistance in Bacteria
  • CAR-T cell therapy research

University Hospital Hradec Králové
2020-2024

Charles University
2020-2024

University of Hradec Králové
2024

Several clinical trials have proved the efficacy and safety of T-cells chimeric antigen receptor (CAR-T cells) in treatment malignant lymphoma first products were registered European Union 2018. The shelf-life CAR-T cell liquid state is short, so cryopreservation offers a significant benefit for logistics manufacturing patient management. Direct shipment cryopreserved therapy to department feasible, nevertheless, intermediate storage hospital cryostorage facility gives advantage planning...

10.54680/fr23310110112 article EN cc-by-nc-nd Cryoletters 2023-05-01

The objective of this study was to evaluate off-label high-dose ceftazidime population pharmacokinetics in cancer patients with suspected or proven extensively drug-resistant (XDR) Pseudomonas aeruginosa infections and then compare the achievement pharmacokinetic/pharmacodynamic (PK/PD) target after standard regimens using model-based simulations. A further aim clinically observe occurrence adverse effects during treatment.In treated (3 g every 6 h), blood samples were collected serum levels...

10.1111/bcp.15612 article EN British Journal of Clinical Pharmacology 2022-11-24

Abstract Despite lower virulence, the omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes disease 2019 (COVID-19) still poses a relevant threat for immunocompromised patients. A retrospective multicentric study was conducted to evaluate efficacy pre-exposure prophylaxis with tixagevimab/cilgavimab (Evusheld) 6-month follow-up preventing COVID-19 in adult patients hematology malignancy. Among 606 cohort, 96 (16%) contracted median 98.5 days after...

10.1007/s00277-023-05572-0 article EN cc-by Annals of Hematology 2023-12-14

<h3>Background and Importance</h3> Optimisation of antibiotic (ATB) administration is vital for improving infection treatment effectiveness. An ATB stewardship programme can help clinicians rationalise prescribing. There no simple effective tool. Last year we conducted an adherence audit with the local guidelines (LG). <h3>Aim Objectives</h3> This study aimed to review LG in terms prescribing administration. <h3>Material Methods</h3> Single-centre prospective prescribed at least 50...

10.1136/ejhpharm-2024-eahp.409 article EN Section 5: Patient safety and quality assurance 2024-03-01

<h3>Background and Importance</h3> According to the global recommendations for COVID-19 therapy, adult patients at risk of severe disease (including after organ transplantation) should be treated with antivirals: preferably nirmatrelvir/ritonavir (Paxlovid) or remdesivir (Veklury). Alternative choice is unlicensed use molnupiravir (Lagevrio). <h3>Aim Objectives</h3> Our study focused on evaluating effectiveness safety in successful kidney transplantation (KTx). <h3>Material Methods</h3> A...

10.1136/ejhpharm-2024-eahp.423 article EN Section 5: Patient safety and quality assurance 2024-03-01

<h3>Introduction</h3> Evidence-based (EB) data on drug dosage optimization in children are already available across Europe. However, their systematic translation was lacking the Czech Republic and Slovakia. The purpose of our project is to create a database (CzechPharmPed) based evidence existing international databases national specifics, that will have positive impact daily clinical practice. objectification this crucial, moreover, provides valuable feedback. <h3>Methododology</h3> After...

10.1136/bmjpo-2024-esdppp.4 article EN other-oa 2024-07-31

Hairy cell leukemia (HCL) is a rare indolent lymphoproliferative disease with an accumulation of mature B lymphocytes fine reticular chromatin and cytoplasm typical hairy-like cytoplasmic projections. Rarely, hairy manifests as lung infiltration. The differential diagnosis between infection malignant involvement often challenging in such situations.We present 53-year-old female uncommon pulmonary leukemia. In addition, we discuss the complicated patients treatment approach to these...

10.5507/bp.2022.026 article EN cc-by Biomedical Papers 2022-06-16

Abstract High doses of corticosteroids in combination with rituximab remain an alternative the treatment relapsed or refractory chronic lymphocytic leukaemia (CLL) current era targeted therapies. This study retrospectively evaluates efficacy RCD (rituximab, cyclophosphamide and dexamethasone) regimen 51 patients CLL (median age, 72 years). Unfavourable prognostic features, such as Rai stage III/IV, unmutated IGHV, del11q, TP53 mutation/deletion, complex karyotype bulky lymphadenopathy, were...

10.1111/eci.13421 article EN European Journal of Clinical Investigation 2020-10-06

Kyselina mravenčí byla pro svoje leptavé účinky v 10-90% koncentraci používána jako jedna z metod léčby virových bradavic.Přestože je dnešní době tato léčba považována za metodu obsolentní (pro možnost vzniku iritační dermatitidy, rizika poleptání a nekrózy s následnou jizvou), stále se touto praxí dermatologických ordinacích setkáváme.Autoři referují dvě kazuistiky kojenců, jejichž společnou příčinou nešťastná záměna lékovek při perorálním podání léčiva

10.36290/ped.2019.024 article CS Pediatrie pro praxi 2019-04-23

Metamizol (dipyron) je v klinické praxi využíván již téměř 100 let jako neopioidní analgetikum se spasmolytickou účinností (zejména vyšší dávky) perioperační léčbě bolesti a antipyretikum druhé volby.Vykazuje dobrý profil nežádoucích účinků, mírné protidestičkové gastrointestinální nežádoucí účinky.Metamizol kontroverzní pro výskyt velmi vzácné idiosynkratické imunologicky podmíněné reakce na úrovni krvetvorby.Tam, kde metamizol používán, jsou účinky agranulocytózy granulocytopenie i nadále...

10.36290/ped.2020.066 article CS Pediatrie pro praxi 2020-10-16

<h3>Background and Importance</h3> At height of COVID-19 pandemic surge delta variant, monoclonal antibodies became a vital treatment option for SARS-COV-2 positive outpatients at high risk severe disease progression. Casirivimab imdevimab (C/I) were used under EMA emergency use authorisation (EUA) there was paucity real-world data on safety effectiveness. <h3>Aim Objectives</h3> The study aimed to describe drug safety, self-reported symptom burden vaccination status in within 90 days...

10.1136/ejhpharm-2023-eahp.290 article EN Section 5: Patient safety and quality assurance 2023-03-01

Introduction Evidence-based (EB) data on various medicaments and safe drug dosing in pediatric population are already available across Europe. However, their systematic translation clear processing lacking daily clinical practice the Czech Republic. The purpose of our work is development a database similar to some existing internationally based formulary lists. Methods A approach recommended dosages drugs used environment, all compiled language. active substances will be arranged according...

10.1136/archdischild-2023-esdppp.26 article EN Archives of Disease in Childhood 2023-05-18

Chronická lymfocytární leukemie (CLL) je nejčastější leukemií dospělých v euroamerické populaci a bývá často komplikována autoimunitními cytopeniemi. U nemocných s anémií trombocytopenií jsou jednou z možných příčin autoimunitní hemolytická anémie (AIHA) imunitní trombocytopenie (ITP), vzácně také čistá aplázie červené řady (PRCA). Posledních několik let máme při léčbě CLL k dispozici nové cílené perorální inhibitory, jejichž použití...

10.36290/xon.2022.029 article EN Onkologie 2022-05-16
Coming Soon ...